Publications by authors named "YuLong Xu"

Claim this Profile
V
Visible light-triggered oxidase-mimicking activity of covalent organic frameworks for colorimetric assessment of total antioxidant capacity in food.
Yulong Xu, Jialu Xu, Wei Zhang, Xingbo Ren, Peng Xia, Xuwei Chen

Food Chem· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Novel PET Radioligand for Imaging the Adenosine A Receptor in the Brain.
Yanli Wang, Yongle Wang, Yulong Xu, Hongzhi Yang, Yafei Huang

ACS Chem Neurosci· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight (LIGHT 1): A randomized, double-blind, placebo-controlled, ascending-dose phase 2a trial.
Fei Gao, Mingxia Yuan, Nianrong Mi, Danfeng Peng, Ruihua Dong, Yulong Xu

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes Remission in Drug-Naïve Patients with Type 2 Diabetes After Efsubaglutide Alfa Treatment.
Rui Sun, Kun Wang, Guoyue Yuan, Bimin Shi, Xueying Wang, Yulong Xu

Adv Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of Efsubaglutide Alfa in "overrun" patients in the SUPER2 trial: A post-hoc analysis for comprehensive evaluation.
Weiping Jia, Fan Jiang, Yulong Xu, Yiming Li, Yuqian Bao

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Treated with Metformin.
Qinghua Wang, Fan Jiang, Yulong Xu, Yuyang Lei, Li Zhang

Clin Pharmacokinet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus.
Qinghua Wang, Fan Jiang, Yulong Xu, Yuyang Lei, Li Zhang

Clin Pharmacokinet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Novel PET Radioligand Targeting PKM2 for Brain Imaging and Alzheimer's Disease Characterization.
Yanli Wang, Yongle Wang, Wei Zhang, Yulong Xu, Nilay S Narayan

J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CX3CR1: a potential microglia-specific PET imaging target in Alzheimer's and Parkinson's diseases.
Hongzhi Yang, Yanli Wang, Yulong Xu, Changning Wang

Front Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid 1 receptor occupancy and neurovascular responses induced by agonist, antagonist/inverse-agonist, and potential modulator in non-human primate brains: PET/fMRI study.
Chi-Hyeon Yoo, Yulong Xu, Frederick A Bagdasarian, Yu-Shiuan Lin, Changning Wang

J Cereb Blood Flow Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
Dalong Zhu, Jianhua Ma, Weimin Wang, Bimin Shi, Xiaolin Dong, Xueying Wang, Ning Xu, Yulong Xu

Diabetologia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Efsubaglutide Alfa on the Pharmacokinetics of Metformin and Digoxin in Healthy Participants.
Xiaojie Wu, Jinjie He, Junzhen Wu, Wei Liu, Yulong Xu

Clin Pharmacokinet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ozone stress alters amino acid and flavonoid metabolism of Ziziphi Spinosae Folium.
Xiangrui Fu, Caihong Li, Mengwei Zhao, Yulong Xu, Lanping Guo

J Hazard Mater· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of Efsubaglutide Alfa in healthy participants: A randomised, dose-escalation phase 1 study.
Qinghua Wang, Qiaoli Cui, Yulong Xu, Gerald J Prud'homme, Yuanxun Yang

Diabetes Obes Metab· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics analysis of lactate metabolism gene regulation in Clonorchis sinensis-associated hepatocellular carcinoma.
Qiumei Lin, Junxian Chen, Lingling Zhou, Min Fang, Caibiao Wei, Yulong Xu

Parasit Vectors· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of a new Carbon-11 labeled positron emission tomography radiotracer for RIPK1 neuroimaging.
Hua Cheng, Yongle Wang, Yanli Wang, Tewodros M Dagnew, Anne Siewko, Yulong Xu

Comput Biol Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel PET radioligand for mitochondrial complex I in nonhuman primate.
Yulong Xu, Yiming Xu, Frederick Andrew Bagdasarian, Tewodros Mulugeta Dagnew, Hua Cheng

Nucl Med Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
infected hepatocellular carcinoma exhibits distinct tumor microenvironment and molecular features.
Junxian Chen, Caibiao Wei, Wencheng Huang, Taijun Huang, Lingling Zhou, Yulong Xu

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalysis-Assisted Synthesis of Two-Dimensional Conductive Metal-Organic Framework Films with Controllable Orientation.
Min Song, Yixuan Wu, Jingjing Jia, Jiahao Peng, Yixiao Ren, Yulong Xu

J Am Chem Soc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes.
Yan-Ru Lou, Yu-Long Xu, Yifeng Xiong, Chenhui Deng, Qinghua Wang

Clin Pharmacokinet· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Development of a Novel BET Protein-Targeted PET Imaging Probe for In Vivo Characterization of Alzheimer's Disease Pathophysiology.
Yanli Wang, Yongle Wang, Yulong Xu, Hua Cheng, Tewodros Mulugeta Dagnew

J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and Band Gap-Regulation of Ordered Macro-Microporous Single Crystals of an Amine-Linked Covalent Organic Framework.
Yulong Xu, Min Song, Yixiao Ren, Xinghan Pang, Jingtian Cheng

ACS Appl Mater Interfaces· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient and Rapid Extraction of Gold from E-Waste via Tailoring the Skeleton Environment of Covalent Organic Framework.
Yulong Xu, Yong Huang, Yuxin Xie, Xuwei Chen

ACS Appl Mater Interfaces· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The microRNA landscape and regulatory network in Clonorchis sinensis-infected hepatocellular carcinoma: implications for tumor progression.
Caibiao Wei, Junxian Chen, Taijun Huang, Lingling Zhou, Yulong Xu

Parasit Vectors· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a PET Probe Targeting Bromodomain and Extra-Terminal Proteins for In Vitro and In Vivo Visualization.
Yongle Wang, Yanli Wang, Yulong Xu, Hua Cheng, Tewodros Mulugeta Dagnew

Pharmaceuticals (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis